LETTERS TO THE EDITOR Direct Acting Antiviral Treatment REFERENCES Selection in a Child With Hepatitis C 1. Indolﬁ G, Thorne C, El Sayed MH, et al. The challenge of treating Virus Infection and children with hepatitis C. J Pediatr Gastroenterol Nutr 2017;64:851–4. 2. Jonas MM. Hepatitis C virus infection in children. UptoDate Website. Compensated Cirrhosis https://www.uptodate.com/contents/hepatitis-c-virus-infection-in-children. Accessed May 25, 2017. 3. American Association for the Study of Liver Diseases. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. o the Editor: We read with interest the article by Indolfi et al 2016. www.hcvguidelines.org. Accessed May 5, 2016. (1) about the issue of treating children with hepatitis C virus 4. Goldschmidt I, Streckenbach C, Dingemann C, et al. Application and (HCV) infection, in connection with the approval, in April 2017, of limitations of transient liver elastography in children. J Pediatr Gastro- 2 new direct-acting antivirals (sofosbuvir plus ribavirin and sofos- enterol Nutr 2013;57:109–13. buvir-ledipasvir) for patients 12 years of age and older (1). How- ever, in some cases, as children in whom prior treatment has failed, little data is available about appropriate treatment selection, so it may be reasonable to consider adult guidelines (2). In this context, we report
Journal of Pediatric Gastroenterology & Nutrition – Wolters Kluwer Health
Published: Mar 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera